![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PTGES |
Gene summary for PTGES |
![]() |
Gene information | Species | Human | Gene symbol | PTGES | Gene ID | 9536 |
Gene name | prostaglandin E synthase | |
Gene Alias | MGST-IV | |
Cytomap | 9q34.11 | |
Gene Type | protein-coding | GO ID | GO:0001516 | UniProtAcc | O14684 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9536 | PTGES | LZE8T | Human | Esophagus | ESCC | 1.39e-02 | 2.31e-01 | 0.067 |
9536 | PTGES | LZE20T | Human | Esophagus | ESCC | 4.35e-12 | 9.43e-01 | 0.0662 |
9536 | PTGES | LZE22T | Human | Esophagus | ESCC | 7.45e-04 | 6.20e-01 | 0.068 |
9536 | PTGES | LZE24D1 | Human | Esophagus | HGIN | 1.13e-02 | 1.06e+00 | 0.054 |
9536 | PTGES | LZE24T | Human | Esophagus | ESCC | 1.44e-04 | 5.23e-01 | 0.0596 |
9536 | PTGES | LZE21T | Human | Esophagus | ESCC | 5.87e-03 | 2.90e-01 | 0.0655 |
9536 | PTGES | LZE6T | Human | Esophagus | ESCC | 1.46e-11 | 1.75e+00 | 0.0845 |
9536 | PTGES | P1T-E | Human | Esophagus | ESCC | 1.79e-06 | 1.24e+00 | 0.0875 |
9536 | PTGES | P2T-E | Human | Esophagus | ESCC | 5.31e-23 | 6.63e-01 | 0.1177 |
9536 | PTGES | P4T-E | Human | Esophagus | ESCC | 5.86e-12 | 5.34e-01 | 0.1323 |
9536 | PTGES | P8T-E | Human | Esophagus | ESCC | 1.85e-32 | 1.21e+00 | 0.0889 |
9536 | PTGES | P11T-E | Human | Esophagus | ESCC | 1.08e-12 | 1.20e+00 | 0.1426 |
9536 | PTGES | P15T-E | Human | Esophagus | ESCC | 1.69e-05 | 4.01e-01 | 0.1149 |
9536 | PTGES | P17T-E | Human | Esophagus | ESCC | 6.20e-08 | 6.62e-01 | 0.1278 |
9536 | PTGES | P21T-E | Human | Esophagus | ESCC | 1.45e-22 | 6.97e-01 | 0.1617 |
9536 | PTGES | P22T-E | Human | Esophagus | ESCC | 7.63e-11 | 2.53e-01 | 0.1236 |
9536 | PTGES | P23T-E | Human | Esophagus | ESCC | 1.27e-18 | 1.47e+00 | 0.108 |
9536 | PTGES | P24T-E | Human | Esophagus | ESCC | 1.52e-18 | 8.49e-01 | 0.1287 |
9536 | PTGES | P26T-E | Human | Esophagus | ESCC | 9.26e-13 | 5.03e-01 | 0.1276 |
9536 | PTGES | P27T-E | Human | Esophagus | ESCC | 8.02e-03 | 1.12e-01 | 0.1055 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00519737 | Breast | Precancer | positive regulation of telomerase activity | 8/1080 | 34/18723 | 5.65e-04 | 7.16e-03 | 8 |
GO:00322003 | Breast | Precancer | telomere organization | 20/1080 | 159/18723 | 8.45e-04 | 9.82e-03 | 20 |
GO:00305187 | Breast | Precancer | intracellular steroid hormone receptor signaling pathway | 16/1080 | 116/18723 | 1.01e-03 | 1.13e-02 | 16 |
GO:00519728 | Breast | Precancer | regulation of telomerase activity | 9/1080 | 47/18723 | 1.28e-03 | 1.36e-02 | 9 |
GO:00463946 | Breast | Precancer | carboxylic acid biosynthetic process | 32/1080 | 314/18723 | 1.30e-03 | 1.38e-02 | 32 |
GO:00510548 | Breast | Precancer | positive regulation of DNA metabolic process | 23/1080 | 201/18723 | 1.34e-03 | 1.41e-02 | 23 |
GO:00723304 | Breast | Precancer | monocarboxylic acid biosynthetic process | 24/1080 | 214/18723 | 1.41e-03 | 1.48e-02 | 24 |
GO:00160536 | Breast | Precancer | organic acid biosynthetic process | 32/1080 | 316/18723 | 1.44e-03 | 1.50e-02 | 32 |
GO:00511317 | Breast | Precancer | chaperone-mediated protein complex assembly | 6/1080 | 23/18723 | 1.57e-03 | 1.61e-02 | 6 |
GO:00066335 | Breast | Precancer | fatty acid biosynthetic process | 19/1080 | 163/18723 | 2.74e-03 | 2.42e-02 | 19 |
GO:00305228 | Breast | Precancer | intracellular receptor signaling pathway | 27/1080 | 265/18723 | 2.99e-03 | 2.57e-02 | 27 |
GO:00434018 | Breast | Precancer | steroid hormone mediated signaling pathway | 16/1080 | 136/18723 | 5.21e-03 | 3.88e-02 | 16 |
GO:000609113 | Breast | IDC | generation of precursor metabolites and energy | 103/1434 | 490/18723 | 1.53e-21 | 1.74e-18 | 103 |
GO:001598013 | Breast | IDC | energy derivation by oxidation of organic compounds | 73/1434 | 318/18723 | 8.70e-18 | 3.80e-15 | 73 |
GO:004854514 | Breast | IDC | response to steroid hormone | 70/1434 | 339/18723 | 1.34e-14 | 4.23e-12 | 70 |
GO:002261314 | Breast | IDC | ribonucleoprotein complex biogenesis | 83/1434 | 463/18723 | 2.01e-13 | 5.20e-11 | 83 |
GO:007182614 | Breast | IDC | ribonucleoprotein complex subunit organization | 52/1434 | 227/18723 | 5.18e-13 | 1.21e-10 | 52 |
GO:002261814 | Breast | IDC | ribonucleoprotein complex assembly | 51/1434 | 220/18723 | 5.32e-13 | 1.21e-10 | 51 |
GO:000645713 | Breast | IDC | protein folding | 47/1434 | 212/18723 | 2.31e-11 | 3.86e-09 | 47 |
GO:006107713 | Breast | IDC | chaperone-mediated protein folding | 21/1434 | 67/18723 | 1.35e-08 | 9.71e-07 | 21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PTGES | SNV | Missense_Mutation | c.296N>T | p.Ala99Val | p.A99V | O14684 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-G4-6628-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PTGES | SNV | Missense_Mutation | c.421N>C | p.Ala141Pro | p.A141P | O14684 | protein_coding | deleterious(0) | probably_damaging(0.971) | TCGA-EI-7002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | irinotecan+5-fluorouracilim | SD | |
PTGES | SNV | Missense_Mutation | rs551621700 | c.365G>A | p.Arg122Gln | p.R122Q | O14684 | protein_coding | tolerated(0.2) | benign(0.024) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PTGES | SNV | Missense_Mutation | c.374T>C | p.Ile125Thr | p.I125T | O14684 | protein_coding | tolerated(1) | benign(0) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PTGES | SNV | Missense_Mutation | c.244N>A | p.Phe82Ile | p.F82I | O14684 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-FV-A3R3-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PTGES | SNV | Missense_Mutation | c.190N>C | p.Asp64His | p.D64H | O14684 | protein_coding | tolerated(0.05) | probably_damaging(0.971) | TCGA-18-3409-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
PTGES | SNV | Missense_Mutation | novel | c.167C>A | p.Pro56His | p.P56H | O14684 | protein_coding | tolerated(0.14) | benign(0.343) | TCGA-37-3789-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
PTGES | deletion | Frame_Shift_Del | c.189delC | p.Asp64ThrfsTer65 | p.D64Tfs*65 | O14684 | protein_coding | TCGA-BR-8078-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
9536 | PTGES | DRUGGABLE GENOME, ENZYME | Benzamide derivative 14 | |||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | Benzimidazole derivative 13 | |||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | VEGF | 16155957 | ||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | Imidazopyridine derivative 5 | |||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | Imidazole benzamide derivative 1 | |||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | inhibitor | 252827532 | ||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | Alpha-substituted pirinixic acid and pirinixic acid ester derivative 1 | |||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | Imidazopyridine derivative 6 | |||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | PMID28627961-Compound-30 | |||
9536 | PTGES | DRUGGABLE GENOME, ENZYME | Methyl-piperidine compound 1 |
Page: 1 2 3 4 5 |